Abstract
This present review submitted high-performance liquid chromatography (HPLC) methods for determining the presence of meloxicam used in clinical treatment within various fields of application, including biological samples and pharmaceutical formulations, between 1990 and 2011.
Meloxicam is a cyclooxygenase-2 selective nonsteroidal anti-inflammatory drug (NSAIDs), which is the group most often used in human health care. We compared the methods from the standpoint of sensitivity. HPLC methods with MS/MS detection have become the method of choice in bioanalytical applications.
Keywords: Meloxicam, HPLC, Review, Pharmaceutical preparations, Biological samples, cyclooxygenase, NSAIDs, sensitivity, hemorrhagia, physiological, methylthiazole system
Current Pharmaceutical Analysis
Title:A Review of HPLC Methods Used for Determining the Presence of Meloxicam
Volume: 9 Issue: 1
Author(s): Monika Brezovska, Josef Jampilek and Radka Opatrilova
Affiliation:
Keywords: Meloxicam, HPLC, Review, Pharmaceutical preparations, Biological samples, cyclooxygenase, NSAIDs, sensitivity, hemorrhagia, physiological, methylthiazole system
Abstract: This present review submitted high-performance liquid chromatography (HPLC) methods for determining the presence of meloxicam used in clinical treatment within various fields of application, including biological samples and pharmaceutical formulations, between 1990 and 2011.
Meloxicam is a cyclooxygenase-2 selective nonsteroidal anti-inflammatory drug (NSAIDs), which is the group most often used in human health care. We compared the methods from the standpoint of sensitivity. HPLC methods with MS/MS detection have become the method of choice in bioanalytical applications.
Export Options
About this article
Cite this article as:
Brezovska Monika, Jampilek Josef and Opatrilova Radka, A Review of HPLC Methods Used for Determining the Presence of Meloxicam, Current Pharmaceutical Analysis 2013; 9 (1) . https://dx.doi.org/10.2174/1573412911309010010
DOI https://dx.doi.org/10.2174/1573412911309010010 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Trends of Biocompatible and Biodegradable Nanoparticles in Drug Delivery: A Review
Current Medicinal Chemistry New Hybrids with 2-aminobenzothiazole and Azelayl Scaffolds: Synthesis, Molecular Docking and Biological Evaluation
Current Organic Chemistry The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?
Current Drug Targets “Letting the Air In” Can Set the Stage for Tumor Recurrences
Current Cancer Therapy Reviews Recent Patents Relating to Tumor Suppressor Genes
Recent Patents on DNA & Gene Sequences Nanotechnology Enabled Drug Delivery Systems for Bone and Cartilage Regeneration
Recent Patents on Biomedical Engineering (Discontinued) Apoptosis Signaling Pathways in Anticancer Therapy
Current Cancer Therapy Reviews Micro-/Nano-Scale Biointerfaces, Mechanical Coupling and Cancer Therapy
Current Topics in Medicinal Chemistry Recent Advances in Thymidine Kinase 2 (TK2) Inhibitors and New Perspectives for Potential Applications
Current Pharmaceutical Design Fertility Preservation in Women After the Cancer
Current Pharmaceutical Design Combined Transcriptomic and Proteomic Analyses of Cerebral Frontal Lobe Tissue Identified RNA Metabolism Dysregulation as One Potential Pathogenic Mechanism in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Current Neurovascular Research Potential Association Between TLR4 and Chitinase 3-Like 1 (CHI3L1/YKL-40) Signaling on Colonic Epithelial Cells in Inflammatory Bowel Disease and Colitis-Associated Cancer
Current Molecular Medicine Melanoma and Epigenetic Treatment: Past and Future
Anti-Cancer Agents in Medicinal Chemistry Protein-Protein Interaction Inhibitors: Small Molecules from Screening Techniques
Current Topics in Medicinal Chemistry Advanced Membrane Systems for Tissue Engineering
Current Organic Chemistry Triterpene Derivatives as Inhibitors of Protein Involved in the Inflammatory Process: Molecules Interfering with Phospholipase A2, Cycloxygenase, and Lipoxygenase
Current Drug Targets Functionalized Nanocarriers for Enhanced Bioactive Delivery to Squamous Cell Carcinomas: Targeting Approaches and Related Biopharmaceutical Aspects
Current Pharmaceutical Design Synthesis and Anticancer Study of Novel 4H-Chromen Derivatives
Anti-Cancer Agents in Medicinal Chemistry Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection
Current Cancer Drug Targets Strategies for Preparing Different Types of Lipid Polymer Hybrid Nanoparticles in Targeted Tumor Therapy
Current Pharmaceutical Design